Federal award
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
W81XWH2211029
Assistance
Obligated and Ceiling
- Obligated (net)
- $225,268.69
- Potential value
- —
- Current value
- —
- Gross positive obligations
- $231,150.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · LTJVF4QSFCP9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- —
- Awarding agency
- Department of Defense · sub-agency 97DH · office HT9425
- Funding agency
- Department of Defense · sub-agency 97DH
- Assistance listing (CFDA)
- CFDA 12.420
- FAIN
- W81XWH2211029
- Award type code
- 04
- Actions
- 3 · Aug 25, 2022 to Mar 20, 2026
- Why it is listed
- a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 20, 2026 | FY2026 | P00002 | FX | −$5,881.31 | — |
| Jul 24, 2024 | FY2024 | P00001 | B1 | $0.00 | — |
| Aug 25, 2022 | FY2022 | 0 | A1 | $231,150.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.